Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.

Ghidewon, M et al.·Diabetes·2022·
RPEP-061352022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Combined treatment with GDF15 and semaglutide resulted in greater weight loss and food intake suppression compared to either treatment alone.

Key Numbers

How They Did This

The study used rat experiments to assess the effects of GDF15 and semaglutide on food intake and weight loss through various behavioral and neural mechanisms.

Why This Research Matters

Understanding how these treatments work can lead to more effective obesity therapies. The distinct mechanisms suggest potential for combination therapies in weight management.

What This Study Doesn't Tell Us

The study was conducted in rats, and results may not directly translate to humans.

Trust & Context

Original Title:
Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.
Published In:
Diabetes, obesity & metabolism, 24(6), 1010-1020 (2022)
Database ID:
RPEP-06135

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06135·https://rethinkpeptides.com/research/RPEP-06135

APA

Ghidewon, M; Wald, H S; McKnight, A D; De Jonghe, B C; Breen, D M; Alhadeff, A L; Borner, T; Grill, H J. (2022). Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.. Diabetes, obesity & metabolism, 24(6), 1010-1020. https://doi.org/10.1111/dom.14663

MLA

Ghidewon, M, et al. "Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.." Diabetes, 2022. https://doi.org/10.1111/dom.14663

RethinkPeptides

RethinkPeptides Research Database. "Growth differentiation factor 15 (GDF15) and semaglutide inh..." RPEP-06135. Retrieved from https://rethinkpeptides.com/research/ghidewon-2022-growth-differentiation-factor-15

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.